Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence
- PMID: 23172780
- DOI: 10.1002/hep.26141
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence
Abstract
In efforts to inform public health decision makers, the Global Burden of Diseases, Injuries, and Risk Factors 2010 (GBD2010) Study aims to estimate the burden of disease using available parameters. This study was conducted to collect and analyze available prevalence data to be used for estimating the hepatitis C virus (HCV) burden of disease. In this systematic review, antibody to HCV (anti-HCV) seroprevalence data from 232 articles were pooled to estimate age-specific seroprevalence curves in 1990 and 2005, and to produce age-standardized prevalence estimates for each of 21 GBD regions using a model-based meta-analysis. This review finds that globally the prevalence and number of people with anti-HCV has increased from 2.3% (95% uncertainty interval [UI]: 2.1%-2.5%) to 2.8% (95% UI: 2.6%-3.1%) and >122 million to >185 million between 1990 and 2005. Central and East Asia and North Africa/Middle East are estimated to have high prevalence (>3.5%); South and Southeast Asia, sub-Saharan Africa, Andean, Central, and Southern Latin America, Caribbean, Oceania, Australasia, and Central, Eastern, and Western Europe have moderate prevalence (1.5%-3.5%); whereas Asia Pacific, Tropical Latin America, and North America have low prevalence (<1.5%).
Conclusion: The high prevalence of global HCV infection necessitates renewed efforts in primary prevention, including vaccine development, as well as new approaches to secondary and tertiary prevention to reduce the burden of chronic liver disease and to improve survival for those who already have evidence of liver disease.
Copyright © 2012 American Association for the Study of Liver Diseases.
Similar articles
-
Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs.Addiction. 2019 Jan;114(1):150-166. doi: 10.1111/add.14393. Epub 2018 Aug 28. Addiction. 2019. PMID: 30035835 Free PMC article.
-
Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes.World J Gastroenterol. 2016 Sep 14;22(34):7824-40. doi: 10.3748/wjg.v22.i34.7824. World J Gastroenterol. 2016. PMID: 27678366 Free PMC article. Review.
-
The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study.Addiction. 2014 Aug;109(8):1320-33. doi: 10.1111/add.12551. Epub 2014 Apr 24. Addiction. 2014. PMID: 24661272
-
Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.Vaccine. 2012 Mar 9;30(12):2212-9. doi: 10.1016/j.vaccine.2011.12.116. Epub 2012 Jan 24. Vaccine. 2012. PMID: 22273662
-
Hepatitis A virus seroprevalence by age and world region, 1990 and 2005.Vaccine. 2010 Sep 24;28(41):6653-7. doi: 10.1016/j.vaccine.2010.08.037. Epub 2010 Aug 17. Vaccine. 2010. PMID: 20723630 Review.
Cited by
-
The role of inflammasome in chronic viral hepatitis.Front Cell Infect Microbiol. 2024 May 16;14:1382029. doi: 10.3389/fcimb.2024.1382029. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38817443 Free PMC article. Review.
-
Prevalence of hepatitis B and C viruses among migrant workers in Qatar.Sci Rep. 2024 May 17;14(1):11275. doi: 10.1038/s41598-024-61725-9. Sci Rep. 2024. PMID: 38760415 Free PMC article.
-
The COVID-19 Pandemic Affected Hepatitis C Virus Circulation and Genotypic Frequencies-Implications for Hepatitis C Prevention, Treatment and Research.Epidemiologia (Basel). 2024 Apr 4;5(2):160-166. doi: 10.3390/epidemiologia5020011. Epidemiologia (Basel). 2024. PMID: 38651388 Free PMC article.
-
Seroprevalence of Hepatitis B and C Viruses and Their Associated Factors Among Military Personnel at Military Camps in Central Gondar, Ethiopia: A Cross-Sectional Study.Infect Drug Resist. 2024 Apr 11;17:1407-1417. doi: 10.2147/IDR.S455562. eCollection 2024. Infect Drug Resist. 2024. PMID: 38628243 Free PMC article.
-
Hepatitis B and hepatitis C virus infections and associated factors among prisoners in Gondar City, Northwest Ethiopia.PLoS One. 2024 Apr 16;19(4):e0301973. doi: 10.1371/journal.pone.0301973. eCollection 2024. PLoS One. 2024. PMID: 38626232 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical